Author response for "Exploring 2-mercapto-N-arylacetamide analogs as promising anti-melanogenic agents: In vitro and in vivo evaluation"

Hee Jin Jung(Pusan National University), Hyung Ryong Moon(Pusan National University), Hau Yin Chung(Chinese University of Hong Kong), Hyeon Seo Park(Pusan National University), Sang Gyun Noh(Pusan National University), Hye Soo Park(Pusan National University), Yujin Park(Daegu-Gyeongbuk Medical Innovation Foundation), Young Eun Kim(Pusan National University), Pusoon Chun(Inje University), Hye Jin Kim(Kyungpook National University Hospital), Da Eun Jeong(Sungkyunkwan University)
Unknown
August 21, 2024
10.1039/d4ob01225a/v2/response1
Cited by 0

Related Papers

Repurposing the anti-malarial drug artesunate as a novel therapeutic agent for metastatic renal cell carcinoma due to its attenuation of tumor growth, metastasis, and angiogenesis
|Oncotarget|2015|76
Two natural eudesmane-type sesquiterpenes from Laggera alata inhibit angiogenesis and suppress breast cancer cell migration through VEGF- and Angiopoietin 2-mediated signaling pathways
|International Journal of Oncology|2017|57
Anti-Aging Effects of Calorie Restriction (CR) and CR Mimetics Based on the Senoinflammation Concept
|Nutrients|2020|54
A Potent Tyrosinase Inhibitor, (E)-3-(2,4-Dihydroxyphenyl)-1-(thiophen-2-yl)prop-2-en-1-one, with Anti-Melanogenesis Properties in α-MSH and IBMX-Induced B16F10 Melanoma Cells
|Molecules|2018|51
<i>In vitro</i> and <i>in silico</i> insights into tyrosinase inhibitors with ( <i>E</i> )-benzylidene-1-indanone derivatives
|Computational and Structural Biotechnology Journal|2019|51